| 1 |
35054318 | Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria. | 2022 Jan 8 |
1 |
| 2 |
32499479 | Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release. | 2020 Jun 4 |
1 |
| 3 |
30678654 | Molecular expression, characterization and mechanism of ALAS2 gain-of-function mutants. | 2019 Jan 24 |
2 |
| 4 |
30737140 | Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias. | 2019 Nov |
1 |
| 5 |
29991557 | Glutamine via α-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis. | 2018 Sep 6 |
1 |
| 6 |
26300302 | Human Erythroid 5-Aminolevulinate Synthase Mutations Associated with X-Linked Protoporphyria Disrupt the Conformational Equilibrium and Enhance Product Release. | 2015 Sep 15 |
2 |
| 7 |
26605136 | Murine erythroid 5-aminolevulinate synthase: Adenosyl-binding site Lys221 modulates substrate binding and catalysis. | 2015 |
1 |
| 8 |
25450364 | Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia. | 2014 Nov 7 |
1 |
| 9 |
22740690 | X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2). | 2012 Aug 17 |
2 |
| 10 |
10727444 | Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia. | 2000 Mar |
3 |